sphingomyelin

Lipid nanoparticles (LNPs) have revolutionized the delivery of genetic therapies, most famously enabling the deployment of mRNA vaccines at a global scale. However, despite their remarkable success, conventional LNPs remain largely confined to a single target organ: the liver. For the field of nanomedicine to [...]